For following the competition: what moved in each program, several studies read as one move.
- IP2 - 0.5% w/w FS2
- denovoSkin(TM)
- Amniotic Tissue Allograft
- + 1 more
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Burns to watchlistEvery Monday by email · turn it off any timePro · free during the beta